335 related articles for article (PubMed ID: 8991080)
1. APRT: a versatile in vivo resident reporter of local mutation and loss of heterozygosity.
Stambrook PJ; Shao C; Stockelman M; Boivin G; Engle SJ; Tischfield JA
Environ Mol Mutagen; 1996; 28(4):471-82. PubMed ID: 8991080
[TBL] [Abstract][Full Text] [Related]
2. In vivo loss of heterozygosity in T-cells of B6C3F1 Aprt(+/-) mice.
Liang L; Deng L; Shao C; Stambrook PJ; Tischfield JA
Environ Mol Mutagen; 2000; 35(2):150-7. PubMed ID: 10712749
[TBL] [Abstract][Full Text] [Related]
3. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination.
Gupta PK; Sahota A; Boyadjiev SA; Bye S; Shao C; O'Neill JP; Hunter TC; Albertini RJ; Stambrook PJ; Tischfield JA
Cancer Res; 1997 Mar; 57(6):1188-93. PubMed ID: 9067291
[TBL] [Abstract][Full Text] [Related]
4. Exposure of mice to arsenic and/or benzo[a]pyrene does not increase the frequency of Aprt-deficient cells recovered from explanted skin of Aprt heterozygous mice.
Fischer JM; Robbins SB; Kannamkumarath SS; Al-Zoughool M; Stringer SL; Talaska G; Caruso JA; Stambrook PJ; Stringer JR
Environ Mol Mutagen; 2006 Jun; 47(5):334-44. PubMed ID: 16649189
[TBL] [Abstract][Full Text] [Related]
5. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice.
Shao C; Deng L; Henegariu O; Liang L; Raikwar N; Sahota A; Stambrook PJ; Tischfield JA
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9230-5. PubMed ID: 10430925
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous Aprt mouse model: detection and study of a broad range of autosomal somatic mutations in vivo.
Vrieling H; Wijnhoven S; van Sloun P; Kool H; Giphart-Gassler M; van Zeeland A
Environ Mol Mutagen; 1999; 34(2-3):84-9. PubMed ID: 10529730
[TBL] [Abstract][Full Text] [Related]
7. Biallelic methylation and silencing of mouse Aprt in normal kidney cells.
Rose JA; Yates PA; Simpson J; Tischfield JA; Stambrook PJ; Turker MS
Cancer Res; 2000 Jul; 60(13):3404-8. PubMed ID: 10910047
[TBL] [Abstract][Full Text] [Related]
8. Homozygous deficiency at autosomal locus aprt in human somatic cells in vivo induced by two different mechanisms.
Hakoda M; Nishioka K; Kamatani N
Cancer Res; 1990 Mar; 50(6):1738-41. PubMed ID: 2306728
[TBL] [Abstract][Full Text] [Related]
9. Reduced apoptosis and increased deletion mutations at Aprt locus in vivo in mice exposed to repeated ionizing radiation.
Liang L; Mendonca MS; Deng L; Nguyen SC; Shao C; Tischfield JA
Cancer Res; 2007 Mar; 67(5):1910-7. PubMed ID: 17332317
[TBL] [Abstract][Full Text] [Related]
10. Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice.
Van Sloun PP; Wijnhoven SW; Kool HJ; Slater R; Weeda G; van Zeeland AA; Lohman PH; Vrieling H
Nucleic Acids Res; 1998 Nov; 26(21):4888-94. PubMed ID: 9776749
[TBL] [Abstract][Full Text] [Related]
11. Autosomal mutants of proton-exposed kidney cells display frequent loss of heterozygosity on nonselected chromosomes.
Grygoryev D; Dan C; Gauny S; Eckelmann B; Ohlrich AP; Connolly M; Lasarev M; Grossi G; Kronenberg A; Turker MS
Radiat Res; 2014 May; 181(5):452-63. PubMed ID: 24758577
[TBL] [Abstract][Full Text] [Related]
12. A novel signature mutation for oxidative damage resembles a mutational pattern found commonly in human cancers.
Turker MS; Gage BM; Rose JA; Elroy D; Ponomareva ON; Stambrook PJ; Tischfield JA
Cancer Res; 1999 Apr; 59(8):1837-9. PubMed ID: 10213488
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice.
Shao C; Yin M; Deng L; Stambrook PJ; Doetschman T; Tischfield JA
Oncogene; 2002 Apr; 21(18):2840-5. PubMed ID: 11973643
[TBL] [Abstract][Full Text] [Related]
14. Mutations causing deficiency of APRT in fibroblasts cultured from human heterozygous for mutant APRT alleles.
Steglich C; DeMars R
Somatic Cell Genet; 1982 Jan; 8(1):115-41. PubMed ID: 7101101
[TBL] [Abstract][Full Text] [Related]
15. [Mutations of resistance to 2,6-diaminopurine and 6-methylpurine that affect adenine phosphoribosyltransferase in Escherichia coli K-12].
Kocharian ShM; Chukanova TI; Sukhodolets VV
Genetika; 1977; 13(10):1821-30. PubMed ID: 348574
[TBL] [Abstract][Full Text] [Related]
16. [Adenine phosphoribosyltransferase (APRT)].
Kamatani N
Nihon Rinsho; 1996 Dec; 54(12):3213-9. PubMed ID: 8976094
[TBL] [Abstract][Full Text] [Related]
17. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
18. Chemical carcinogens induce varying patterns of LOH in mouse T-lymphocytes.
Wijnhoven SW; Sonneveld E; Kool HJ; van Teijlingen CM; Vrieling H
Carcinogenesis; 2003 Jan; 24(1):139-44. PubMed ID: 12538359
[TBL] [Abstract][Full Text] [Related]
19. Mitotic recombination is suppressed by chromosomal divergence in hybrids of distantly related mouse strains.
Shao C; Stambrook PJ; Tischfield JA
Nat Genet; 2001 Jun; 28(2):169-72. PubMed ID: 11381266
[TBL] [Abstract][Full Text] [Related]
20. Carcinogen-induced loss of heterozygosity at the Aprt locus in somatic cells of the mouse.
Wijnhoven SW; Van Sloun PP; Kool HJ; Weeda G; Slater R; Lohman PH; van Zeeland AA; Vrieling H
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13759-64. PubMed ID: 9811874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
